SRS Capital Advisors »

Foghorn Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.5k 1.1k 4.88
2025-09-30 $2.5k 519 4.89

More positions owned by SRS Capital Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Comfort Systems USA (FIX)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Index Fds Value Etf (VTV)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for SRS Capital Advisors

Top funds holding Foghorn Therapeutics

Flagship Ventures Management
BVF
FMR
Deerfield Management Company
BlackRock
Raymond James Financial
Euclidean Capital
Vanguard Capital Management
Geode Capital Management
Siren
State Street Corporation
Ameriprise Financial
Renaissance Technologies
Candriam Luxembourg S.C.A.
Northern Trust

View all funds holding Foghorn Therapeutics